Journal of Patient-Centered
Research and Reviews
Volume 8

Issue 2

Article 1

4-19-2021

Musings on Patient Willingness to Pay
Dennis J. Baumgardner

Follow this and additional works at: https://aah.org/jpcrr
Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Community
Health and Preventive Medicine Commons, Health Services Research Commons, and the Primary Care
Commons

Recommended Citation
Baumgardner DJ. Musings on patient willingness to pay. J Patient Cent Res Rev. 2021;8:83-5. doi:
10.17294/2330-0698.1851

Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the
Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal
focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes,
and the patient experience.

FROM THE EDITOR

Musings on Patient Willingness to Pay
Dennis J. Baumgardner, MD | Editor-in-Chief
Department of Family Medicine, Aurora UW Medical Group, Advocate Aurora Health, Milwaukee, WI

I

n this issue of the Journal of Patient-Centered
Research and Reviews (JPCRR), an article by Floyd
and colleagues (see p. 98) describes patient-reported
willingness to pay (WTP) for treatment to restore their
chronically diseased knee to ideal function.1 The mean
U.S. dollar amount for patients from a single orthopedic
practice in South Carolina, as measured in 2018, was
$18,704. The total WTP amount generally increased with
higher income category, as anticipated. Subjects reported
a mean WTP of $291 for each 1-unit improvement on a
100-point percentage of normal scale regarding their knee.1
My fascination with measurements such as WTP
prompted a distinctly nonsystematic sampling of
WTP literature from developed countries to see what I
could glean. Intuitively, WTP should vary with patient
perception of their symptoms or disability, the value
they place on them, their level of total or disposable
income, cultural and demographic factors, competing
priorities, and personal philosophy. Indeed, most of
these assumptions are borne out.2-8 Interestingly, WTP
does not appear to correlate with quality-adjusted lifeyear measurements, at least in some studies.9,10 Adjusting
for exchange rate when necessary,11 and for inflation
from the time period in each study to 2018 U.S. dollars,12
I calculated hypothetical WTP (out of pocket) from
a sample of 13 survey-format studies for a variety of
medical procedures or cures.
Conditions, Treatments

Continuing with the subject tackled by Floyd et al,
namely relief for symptoms of knee osteoarthritis, a 2012
study of 2073 subjects in 5 European countries found
WTP of $49 per course of corticosteroid joint injections
and $89 per course of viscosupplement injections.6 WTP
amount correlated with level of disposable income. An
earlier study from Texas found race/ethnicity differences,
which explained 21%–30% of the variation in log WTP
for improvement in arthritic knee symptoms.2 This study
reported that White (non-Hispanic), Hispanic, and African
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American subjects expressed
WTP at 52%, 37%, and 28%
of their mean income values,
respectively, for relief of
severe osteoarthritis. This
compares to 4.5%, 7.1%, and
25.5%, respectively, of mean
income for a week’s vacation,
and 3.1%, 3.7%, and
10.0%, respectively, to have
their house painted. Once
individual
characteristics
and income were controlled for, there were no statistical
differences in WTP between the 3 race/ethnicity
groups for nonhealth expenditures. Controlling for
income differences between groups, log WTP remained
significantly different for White vs African American
subjects but not for White vs Hispanic subjects.2
A study of 40 psoriasis patients in Massachusetts
(45% with income of ≤$54,500) found mean WTP for
hypothetical cure to be $2422 for physical and emotional
relief and $757 for ability to sleep.13 A 2008 study of 197
members of an Australian self-help group had an average
WTP of $5540 (including 20% who expressed a WTP as
high as $29,157) for complete resolution of tinnitus.14
Gan and colleagues studied WTP regarding intraand postoperative complications of subjects in North
Carolina.3,15 Median WTP for a monitor to avoid
intraoperative awareness among 60 individuals was
$47, given a baseline incidence of 5 out of 1000 cases.15
Median WTP for a completely effective postoperative
antiemetic was $82 ($146 if vomiting had been
experienced in a previous postoperative state).3 In the
80-subject study population, WTP increased for those
with higher income, with history of postoperative nausea
or vomiting, who placed more individual importance on
those symptoms, and who were married.3
Screenings and Tests

Regarding screening tests and medical decision-making,
a multisite national study found WTP for a web-based
decision support system among 248 men with newly
diagnosed localized prostate cancer was $27 above usual
care.7 WTP was significantly associated with income,
aah.org/jpcrr
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marital status, stage of decision-making, and starting
“bid” in the iterative bidding survey. A study of WTP for
predictive tests without immediate treatment implications
among 2223 U.S. adults ranged from $126 to $304.8 WTP
varied with income, the particular disease, whether the
test was “perfect” or “imperfect,” and study-measured
risk-taking behavior (lower risk-taking individuals were
less likely to want a test).

In Charles Dickens’ A Christmas Carol, Ebenezer
Scrooge changes his miserly attitude only after three
ghosts show him the error of his ways. I sometimes
wonder if a visit from “the ghost of chronic disease
future” would impact patients more than any clinical
words of wisdom. As for the here and now, how do we
adequately educate our patients regarding risk of lifechanging events?

A 2012 vignette-based study of 3469 patients in the
United Kingdom (64% with annual income of ≤$42,650)
regarding cancer screening in primary care revealed WTP
amounts of $643 for colorectal, $584 for lung (chest
X-ray), and $638 for pancreatic screening.16 Only lung
screening showed a variation in WTP according to pretest
probability.

Submissions to JPCRR addressing effective patient
education on the value of chronic disease management
would be most welcome.

Chronic Disease

Hypothetical WTP for a subject treatment visit (if not
provided at no cost) as part of a patient-centered blood
pressure control research study set in southeastern
Michigan was found to be $27 in a pilot of 38 subjects.17
Massachusetts parents of 638 children 2–12 years of age
were queried regarding WTP for continuing in a pediatric
weight management program.5 A minority (31%) of
parents indicated WTP to receive enhanced primary
care for this purpose and would pay a median of $21 per
month; 45% had WTP for enhanced primary care plus
individual coaching (median WTP of $29 per month).
Tangential to the relative dearth of articles on WTP
for programs aimed at helping control chronic medical
problems in the United States are a pair of European
studies. After having attended an educational program,
202 German patients expressed WTP of $23–$61 per
month to attend a primary care-based health educational
program (no correlation with income).18 Internet
questionnaire results from 461 Swedish patients with
type 2 diabetes revealed a WTP of $25 per month to lose
1 kg of weight, $60 per month to decrease hypoglycemic
episodes from 3 to 1 per month, and $81 per month to
avoid nausea completely.19
I have known patients with disabling, severely painful
arthritis and unrelenting tinnitus, thus the relatively high
WTP in these subject populations is not surprising.1,2,14
It would certainly be hard for me personally to put a price
on relief of some acute symptoms. All debate about
third-party payment aside, as a primary care physician,
I was struck by the apparent lower WTP for treatment
of chronic diseases.5,17-19 I have always struggled to
know how to push the asymptomatic or minimally
symptomatic potential killers (hypertension, chronic
kidney disease, etc) higher up a patient’s priority list.
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